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Status 1 is the listing category reserved for patients awaiting liver transplantation who are at risk of imminent death. This high
allocation priority was intended to benefit patients with acute liver failure and children with severe chronic liver failure. However,
the status 1 criteria were not well defined. The aims of this study, which used the Organ Procurement and Transplantation
Network/Scientific Registry of Transplant Recipients database for patients wait-listed between February 27, 2002, and
September 30, 2003, were to determine the indication and numbers of children and adults at status 1 (including regional
variations); examine death rates on the waiting list for children at vs. not at status 1; and examine time to death, transplant, or
removal from the waiting list for both pediatric and adult status 1 candidates. During the study period, 40.3% of children and
6.1% of adults were transplanted at status 1. The indication was acute liver failure in 52.1% of adults and 31% of children.
Among status 1 transplants, Regional Review Board exceptions were granted for 16.7% of children and 10.1% of adults. Death
rates for children listed at status 1 by exception per patient-year at risk were substantially lower (0.51) than those of children
with acute liver failure (4.06) or with chronic liver disease and Pediatric End-Stage Liver Disease score 25 (4.63). The
percentage of adults who died while on the waiting list within 90 days of listing was more than twice that of children, whereas
the percentages transplanted were similar. Patients listed and transplanted at status 1 were a heterogeneous population with
an overrepresentation of children with varying degrees of chronic liver disease and other exceptions, and an associated wide
variation in waiting list mortality. Recent changes in status 1 criteria provide stricter definitions, particularly for children,
including the removal of the “by exception” category, with the intent that all candidates listed at status 1 share a similar mortality
risk. Liver Transpl 13:699-707, 2007. © 2007 AASLD.
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The intent of the status 1 listing designation for pa-
tients awaiting liver transplantation is to efficiently and
rapidly direct donor organs to patients at risk of immi-
nent death. Although this concept is well accepted and
supported by liver transplant professionals familiar
with these patients’ rapid progression to death, defining
this patient population and judging what constitutes
“imminent” death has been more difficult. If defined by
diagnosis, the patients most obviously eligible for such
a designation are those with acute liver failure, classi-
cally defined1 as no preexisting liver disease with the
acute onset of liver failure within 8 weeks. However,
also eligible for this category are patients with liver
failure after liver transplantation that is the result of
the complications of primary nonfunction (PNF) or he-
patic artery thrombosis (HAT), as well as patients with
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acute decompensated Wilson disease. More difficult to
categorize are those patients with chronic liver disease,
irrespective of diagnosis, who are in the rapidly termi-
nal phase of their disease and have a life expectancy of
only a few days.
In attempts to incorporate prioritization for such
gravely ill patients into liver allocation algorithms, Or-
gan Procurement and Transplantation Network (OPTN)
policies for these most urgent patients have evolved
through several iterations over the years. In 1987,
“UNOS-Stat” identified any candidate expected to live
24 hours. In 1991, the designation of status 1 was
further refined to include adults or children in an in-
tensive care unit (ICU) with either acute or chronic liver
disease and with a life expectancy of 7 days. However,
in response to the growing numbers of severely decom-
pensated adults with chronic liver disease and the in-
creasingly evident donor organ shortage, a less urgent
category (status 2A) was established in 1997 for adults
with chronic liver disease. Children with chronic liver
disease could still be listed at status 1. With the estab-
lishment of the Regional Review Board (RRB) process in
1997, any patients with approval of the RRB could be
listed as status 1, including patients whose liver func-
tion was relatively well preserved but in whom the ex-
trahepatic manifestations of their disease were life-
threatening. For children with metabolic diseases such
as Crigler-Najjar syndrome and urea cycle enzyme de-
ficiencies, this exception was considered important be-
cause it allowed timely transplantation before devastat-
ing central nervous injury occurred.
A major change in the philosophy of liver allocation
occurred as a result of the Institute of Medicine’s report
in 1999,2 and as a consequence, the so-called Final
Rule, issued by the U.S. Health Resources and Services
Administration in 1999, required that organs be allo-
cated to patients on the liver waiting list as ranked by
the severity of their disease, irrespective of time spent
waiting for an organ. This mandate resulted in the de-
velopment of severity of illness scores for both children
and adults with chronic liver disease: the Pediatric
End-Stage Liver Disease (PELD) score for children3 and
the Model for End-Stage Liver Disease (MELD) score for
adults.4,5 These scores, which were developed by using
statistical models that were based on large national
databases, predicted the risk of death while on the
waiting list. Each candidate’s position on the waiting
list was determined by his or her MELD or PELD score.
All patients with chronic liver disease would therefore
be ranked by MELD or PELD score, but review of indi-
vidual cases for assignment of an exception score by the
RRB was preserved. As a consequence, status 2A for
adults with severe chronic liver disease was abolished.
However, children (18 years of age) with severely de-
compensated chronic liver disease could be listed at
status 1, provided they were located in an ICU and had
at least one of the following conditions: ventilator de-
pendence, upper gastrointestinal bleeding, hepatorenal
syndrome, stage 3 or 4 encephalopathy, refractory as-
cites, or biliary sepsis requiring pressor support. The
status 1 provision for pediatric candidates was in-
tended to address the high waiting list mortality rate
among children, particularly those younger than 2
years of age. This high death rate arose not only from
the fragility of very small children, but from the diffi-
culty in finding small donor livers for small recipients in
a timely fashion.
The MELD- and PELD-based liver allocation system
was initiated on February 27, 2002, and included the
following status 1 definitions: adults and children with
acute liver failure including HAT, PNF, and decompen-
sated Wilson disease; children with chronic liver dis-
ease as defined by specific criteria (adults with chronic
liver disease were excluded); and adults and children
with exceptional conditions (not defined) with retro-
spective RRB approval.
To understand the effect of the current status 1 def-
inition on liver transplantation in the MELD and PELD
era, we performed 3 analyses. First, the number of
patients transplanted at status 1 was compared with
those transplanted at their MELD or PELD score. The
subcategories of status, regional differences, and donor
organ type were also examined. Second, we assessed
the waiting list death rates for status 1 and non–status
1 children. Third, we assessed the time to death, trans-
plant, or removal from the waiting list for both pediatric
and adult status 1 candidates.
MATERIALS AND METHODS
Data Sources
The data used in this study were obtained from the
OPTN/Scientific Registry of Transplant Recipients da-
tabase, which contains information on all wait-listed
candidates and transplant recipients in the United
States. Data on mortality were supplemented with in-
formation from the Social Security Death Master File.6
We examined characteristics of donors and recipients of
liver transplants that took place between February 27,
2002, and September 30, 2003. The analyses of adult
and pediatric candidates on the liver waiting list in-
cluded candidates placed on the waiting list during this
period, with follow-up extending through December 31,
2003. Candidates waiting for a combined liver-intestine
transplant were excluded.
Analytic Methods
Status 1 liver candidates and recipients were divided
into 4 main indications for status 1 designation: those
with acute liver failure, those with PNF or HAT, those
with chronic liver disease (meeting criteria), and those
at status 1 by exception (granted by an RRB). The per-
centages of children and adults transplanted within the
4 subgroups of status 1 were examined both nationally
and by region. Pediatric status 1 candidates with
chronic liver disease were further subdivided into 2
groups by using their calculated PELD score with a
threshold of 25.
For candidates on the liver waiting list, we examined
rates of removal from the waiting list over the first 90
days after being made status 1 for reasons of death,
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transplantation, recovery, or becoming too sick to
transplant. Removal rates were assessed for children
and adults in each status 1 subcategory.
For the third analysis, mortality rates on the waiting
list for children were compared among 5 subgroups of
status 1. Candidates were followed from the time at
which they first became active as status 1 until death,
transplantation, or the end of the study, whichever was
earliest. In order to avoid missing deaths occurring
shortly after removal from the waiting list or a switch to
inactive status, candidates were followed for 30 days
after moving to inactive status or removal from the
waiting list for reason other than transplantation.
Death rates were calculated as the number of deaths
divided by the total number of patient-years spent in
that category.
RESULTS
During the study period, 365 (40.3%) of 906 pediatric
liver transplant recipients were status 1 at the time of
transplant, compared with 476 (6.1%) of 7800 adult
recipients. Among pediatric status 1 recipients, 31.0%
were transplanted for acute liver failure, 13.4% for PNF
or HAT, 31% for chronic liver disease (meeting standard
criteria), and 16.7% by exception. In contrast, 52.1% of
adults transplanted at status 1 had acute liver failure,
33.2% had PNF or HAT, and 10.1% had exceptions. One
child and 11 adults were transplanted for decompen-
sated Wilson disease. Figure 1 shows the percentages of
children and adults transplanted by MELD or PELD
score and at status 1 during the study period.
Regional differences in the percentages of children
and adults transplanted at status 1 are shown in Figure
2. In the 9 regions where an average of 20 pediatric
liver transplants per year were performed, the percent-
age of children transplanted at status 1 ranged 11.1 to
59.2% (median, 36.8%). The percentage of adults trans-
planted at status 1 over all 11 regions ranged 3.3 to
12.6% (median, 4.9%).
Table 1 shows the mean calculated MELD and PELD
scores for adults and children transplanted at status 1
for those with acute liver failure, PNF or HAT, chronic
liver disease meeting criteria, and “by exception.” The
mean PELD score for the combined group of children
listed at status 1 for acute liver failure and PNF or HAT
was statistically significantly higher than for those sta-
tus 1 children with chronic liver disease criteria (mean
PELD 25.8 vs. 22.0, respectively; P  0.02) and for
those children transplanted at status 1 by exception
(mean PELD 13.4, P  0.0001). The mean PELD for
pediatric status 1 recipients with chronic liver disease
was also significantly higher than that of children
transplanted at status 1 by exception (P  0.001).
Death Rates on the Waiting List for Children
Transplanted at Status 1
Table 2 shows the number of patient-years, number of
deaths, death rate per year, median PELD score, and
median days to death (among candidates who died) for
each status 1 category. The highest death rates were
seen for children with acute liver failure, PNF or HAT,
and those with chronic liver disease whose PELD scores
were at least 25. The death rate was substantially lower
for children who were status 1 by exception. For com-
parison, Figure 3 shows death rates on the waiting list
for all children listed during the same period at a PELD
score. The death rate for children at status 1 by excep-
tion was comparable to that of children wait-listed
with a PELD score of 22-26. The dropoff in the mor-
tality risk at PELD scores 35 is explained by the
movement of these children into the status 1 cate-
gory. (When not censoring at movement to status 1,
the death rate for PELD 35 is 2.66.) Among candi-
dates who died, children with acute liver failure, PNF,
or HAT died at a median of 4.5-5.5 days after listing,
whereas children with chronic liver disease or those






























Figure 1. Adult and pediatric
liver recipients by MELD or
PELD score and status 1.
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Time to Removal From the Waiting List for
Status 1 Children and Adults
Status 1 liver-only candidates (adults and children)
added to the liver waiting list were divided into the
following subcategories: acute liver failure, PNF or HAT,
RRB exception, MELD or PELD score 25, and MELD
or PELD score 25. Events after being placed on the
liver waiting list were compared among pediatric and
adult status 1 subcategories. Table 3 lists the number
and percentage of adults and children in each category.
The percentage of adults transplanted for acute liver
failure (54.2%) was considerably higher than the per-
centage for children (39.3%). In contrast, only 11.4% of
adults were listed at status 1 by exception or for any
reason other than acute liver failure or PNF or HAT,
compared with 41.3% of children. In particular, the
second most common category for status 1 listing for
children was the category of chronic liver disease with
PELD score 25 (19.8%).
For patients in each status 1 category, we examined,
from day 0—90 after listing, the number of patients
transplanted (either at the same status as listed or at a
different status), number of patients who died (at the
same status, at a different status, or after removal from
list), number of patients removed from the list before
transplant (because of improvement, becoming too sick
to transplant, or for any other reason), and number of
patients remaining on the list (at the same status, at a
different status, or becoming inactive on the list). A
summary of these data is displayed graphically (Fig. 4)
over the first 90 days after listing for the major outcome
































Figure 2. Regional differences
in liver transplantation at sta-
tus 1.
TABLE 1. MELD or PELD Scores at Transplant Among Liver Recipients Listed at Status 1,
February 27, 2002, to September 30, 2003
Characteristic
Adult Child
MELD at transplantation PELD at transplantation
n Mean n Mean
Acute disease 406 31.6 162 25.8*
Acute liver failure 248 34.5 113 27.2
PNF or HAT 158 27.1 49 22.7
Wilson disease 11 40.5 1 7.0
Chronic disease† 113 22.0‡
By RRB exception 48 24.8 61 13.4
Abbreviations: MELD, Model for End-Stage Liver Disease; PELD, Pediatric End-Stage Liver Disease; PNF, primary
nonfunction; HAT, hepatic artery thrombosis; RRB, Regional Review Board.
*P  0.02 compared with mean PELD for recipients with chronic disease (22.0) at time of transplantation; P  0.0001
compared with mean PELD for recipients with status 1 by RRB exception (13.4).
†Excluding hepatoblastoma (N  11), urea cycle defects (N  15), and cases where the reason for status 1 was not given (N 
13).
‡P  0.001 compared with mean PELD for recipients with status 1 by RRB exception (13.4).
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moved from the list, made inactive on the list, or re-
mained active on the list. Figure 4 shows the events
over 90 days after listing for adults and children, com-
paring those with acute liver failure (Fig. 4a), PNF or
HAT (Fig. 4b), and RRB exception (Fig. 4c).
These figures demonstrate that most removals from
the waiting list occurred between 7 and 14 days after
listing. Table 4 provides the actual numbers of patients
and their outcome in status 1 or with change of status
on the waiting list 14 days after status 1 listing. For
both adults and children with fulminant liver failure
who were transplanted, almost all remained at status 1
until transplant. However, approximately half of both
adults and children who died were at another status or
had been removed from the waiting list. The death rates
for children and adults listed at status 1 for fulminant





























Figure 3. Death rates for all
children on the waiting list be-
tween February 27, 2002, and
September 30, 2003.













status 1 listing to
death
Acute liver failure 5.9 24 4.06 29 5.5
PNF or HAT 3.0 12 4.04 23 4.5
Chronic disease: PELD 25 1.5 7 4.63 32 21.0
Chronic disease: PELD 25 4.1 10 2.42 8 15.5
By RRB exception* 3.9 2 0.51 8 24
Abbreviations: PELD, Pediatric End-Stage Liver Disease; PNF, primary nonfunction; HAT, hepatic artery thrombosis; RRB,
Regional Review Board.
*Excluding hepatoblastoma and urea cycle defects.
















Adults (n  878) 476 (54.2%) 302 (34.4%) 65 (7.4%) 27 (3.1%) 8 (0.9%)
Children (n  486) 191 (39.3%) 86 (17.7%) 65 (13.4%) 48 (9.9%) 96 (19.8%)
Abbreviations: PNF, primary nonfunction; HAT, hepatic artery thrombosis; RRB, Regional Review Board; PELD, Pediatric
End-Stage Liver Disease; MELD, Model for End-Stage Liver Disease.
LIVER TRANSPLANTATION FOR STATUS 1 703
LIVER TRANSPLANTATION.DOI 10.1002/lt. Published on behalf of the American Association for the Study of Liver Diseases







0 7 14 21 28 60 90
Days After Entering Status 1




















0 7 14 21 28 60 90
Days After Entering Status 1





















0 7 14 21 28 60 90





















0 7 14 21 28 60 90





















0 7 14 21 28 60 90





















0 7 14 21 28 60 90















c. Patients at Status 1 by Exception 
Active on WL Inactive on WL Removed from WL Transplanted Died
Figure 4. Events on the waiting
list for first 90 days after listing:
status 1 adults (left) and children
(right).









Adults (n  476) 22.7 48.5 6.3 22.5
Children (n  191) 9.9 53.4 16.8 19.9
PNF or HAT
Adults (n  302) 10.6 52.3 4.6 32.5
Children (n  86) 11.6 51.2 14.0 23.3
By RRB exception, children (n  65) 1.5 55.5 38.4 6.2
PELD
25 (n  48) 8.4 60.4 22.9 8.4
25 (n  96) 6.2 44.8 46.8 2.0
Abbreviations: PNF, primary nonfunction; HAT, hepatic artery thrombosis; RRB, Regional Review Board; PELD, Pediatric
End-Stage Liver Disease.
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DISCUSSION
The intent of the status 1 category for liver transplant
candidates was to give the highest priority to a select
group of the sickest patients awaiting liver transplan-
tation. This goal has been largely achieved for adult
candidates: the status 1 criteria for adults remain re-
stricted to the manifestations of acute liver failure, and
a relatively small percentage of adults are transplanted
at status 1. In comparison, children with chronic liver
disease, meeting rather loosely defined criteria, have
been eligible for status 1 or have been assigned status 1
through the exception process after RRB approval. As a
result, 40.3% of all children transplanted over the time
period of this study were status 1 at the time of trans-
plant. This percentage is similar to the 48% reported in
the pre-PELD era,7 suggesting that pediatric transplant
specialists gained little confidence that the PELD sys-
tem would accurately prioritize the sickest children
with chronic liver disease for transplantation.
Shneider et al.8 and Salvalaggio et al.9 reported that
53% and 52% of children, respectively, were not trans-
planted at their calculated PELD score. Additionally,
the granting of pediatric exception cases was noted to
be subject to wide regional variation.9 The result is a
large, heterogeneous population of children listed or
subsequently upgraded to status 1, with a correspond-
ingly wide range of probability of death while on the
waiting list. This variation is clearly shown by our find-
ing that the death rate for children at status 1 ranged
0.51 to 4.6 deaths per patient-year at risk. The inability
to discriminate the risk of death within this diverse
population of children listed at status 1 has meant that
waiting time has driven the allocation of deceased do-
nor livers within the status 1 pediatric candidate pool.
Not only has this contravened the federal directive to
prioritize candidates for transplantation on the basis of
urgency,2 but it has resulted in more children with less
urgent need being transplanted ahead of children with
acute liver failure. Additionally, some adolescent pedi-
atric donor livers that were suitable for an adult with
acute liver failure have been directed to children with
chronic liver disease despite their having a much lower
risk of death. Particularly relevant to the bypassing of
adults with acute liver failure in favor of children with
chronic liver disease is the observation in this study
that twice as many adults as children died at status 1
(20% vs. 10%, respectively).
In the analysis of events on the waiting list over the
first 90 days after listing at status 1, it is apparent that
for both children and adults with acute liver failure or
PNF or HAT, the majority of deaths and transplants
occurred within 14 days, which is consistent with the
original intent of the status 1 definition: directing donor
livers to those thought to face death imminently. The
most obvious difference in events on the list over the
first 90 days is evident in the comparison of children
listed at status 1 by RRB exception to children or adults
with acute liver failure listed at status 1. For children
listed at status 1 by exception, the percentage who died
within 14 days was very small (1.5%) compared with the
percentages of children and adults with acute liver fail-
ure (9.9% and 22.6%, respectively. By 90 days, 80.0%
of children listed at status 1 by exception received a
transplant—a much higher proportion than seen for
any other category of status 1, either adults or children.
This result is explained by a lower overall risk of death
on the waiting list for the status 1 by exception sub-
group. This same subgroup also had the smallest per-
centage of children removed from the list for reasons
other than death or transplant, and had the largest
fraction of patients still active on the list 90 days after
listing.
As a consequence of the results presented in these
analyses, proposals to redesign eligibility criteria for
status 1, for both adults and children, were made by the
OPTN Liver and Intestinal Organ Transplantation and
Pediatric Transplantation Committees. The intent of
these changes was to restrict the status 1 designation
to groups of patients with highly urgent transplant need
and similar probabilities of death on the waiting list.
Another goal was to refine the eligibility criteria defining
status 1 to be both objective and verifiable. Given that
the pathophysiology and tempo of clinical deterioration
is different for acute liver failure (including acute liver
failure secondary to HAT or PNF), and that the highest
early death rates for both adults and children, but es-
pecially for adults, were seen for those with acute liver
failure, a new category of status 1A was established for
these patients that would supersede any child with
chronic liver failure. The criteria for status 1A for both
adults and children are shown in Table 5.
A new status 1B category was designated for children
who have chronic liver disease, have a PELD score of at
least 25, and meet specific criteria. As the data in this
study show, a PELD score of at least 25 was associated
with a risk of death similar to that of children with acute
liver failure, although the mean time to death was
longer for children with chronic liver disease. The eligi-
bility criteria for status 1B are shown in Table 5. Be-
cause grading of hepatic encephalopathy is at best sub-
jective and is often impossible to assess in small
children, the Glasgow Coma Score was accepted in its
place. This score of neurologic status is a routine part of
the daily monitoring record of ICU patients. Although
the score was developed for the assessment of neuro-
logic function after head trauma,10 Tissieres et al.11
found a correlation between a Glasgow Coma Score of
8 (as well as bilirubin, international normalized ratio
of prothrombin time, and unreactive bilateral mydria-
sis) and mortality in children with acute liver failure.
The advantage of the Glasgow Coma Score is that the
clinical observations that make up the score are objec-
tive. For the status 1B criteria, a maximum Glasgow
Coma Score of 10 was chosen as the required measure
of neurologic assessment that most closely approxi-
mated the clinical description of grade 3 hepatic en-
cephalopathy.
An essential feature of the new status 1A and 1B
definitions, and one that is true to the primary goal of
reserving this designation for patients with comparable
risks of dying on the waiting list, is their exclusion of
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exception cases that were previously eligible for status
1 listing by the RRB. The RRBs now have the increased
responsibility to more accurately determine how to
award additional MELD or PELD points when prioritiz-
ing exceptional cases within their region. Voigt et al.12
showed that RRBs’ assignment of MELD or PELD points
could accurately distinguish high- and low-risk pa-
tients, whereas referring physicians predicted pre-
transplant mortality poorly. Regional variation in how
these decisions are made will, we hope, decrease with
the adoption of the MELD exception guidelines recently
approved by the OPTN and circulated to the wider
transplant community. However, such guidelines are
not well established for children, and they cannot take
into account every exceptional circumstance. As RRBs
are made up of physicians and surgeons within the
region, the potential conflict between local or center
interests and what is in the best interest of the region
remains an inherent flaw in the RRB system.
The new status 1 criteria were incorporated into the
liver allocation system in the United States on August
24, 2005, coinciding with broader sharing for pediatric
candidates listed at status 1. Broader sharing is also
important for timely allocation of deceased donors to
these most urgent patients. In a single-center experi-
ence, Humar et al.13 showed that region-wide sharing
for status 1 candidates decreased waiting list mortality
from 32% to 5% over an 8-year period. Organs from
pediatric donors (age 18 years) are now offered first to
pediatric status 1A candidates within the service area
of the procuring organ procurement organization (lo-
cal), then to status 1A–listed children in the region,
followed by local then regional status 1A adult candi-
dates, followed by local then regional status 1B candi-
dates, and then to children aged 0-11 throughout the
region ranked by descending PELD score. The complete
algorithm for deceased donor liver allocation is avail-
able at http://www.optn.org/.
It is too early to evaluate the effects of these changes
in allocation policy, particularly with respect to waiting
list death rates. Also to be considered is that adults and
children with acute liver failure not meeting status 1
criteria will be ranked by MELD or PELD scores. Al-
though MELD and PELD were both developed to predict
mortality in patients with chronic liver disease, there is
some evidence that they accurately assess prognosis in
acute liver failure. Yantorno et al.14 showed that a
MELD score 30 in adults and children with acute liver
failure predicted mortality better than either the Clichy
or London criteria, with a diagnostic accuracy of 95%.
In another study, Kremers et al.15 demonstrated that
MELD score was statistically significantly associated
with poor survival probability for nonacetaminophen-
associated acute liver failure but that it did not predict
mortality for patients with PNF listed within 7 days after
transplant.
Further studies are needed to understand whether
MELD and PELD scores are the most appropriate
means to determine the urgency for transplantation for
patients with acute liver failure not meeting status 1
criteria. In such analyses, a more appropriate endpoint
might be the score’s accuracy in predicting a switch to
status 1, rather than its ability to predict death on the
waiting list. In a preliminary univariate analysis of the
Studies of Pediatric Liver Transplantation database,
PELD score at listing was associated with moving to an
ICU (used as a surrogate for status 1) among children
with acute liver failure. In a preliminary multivariate
analysis of the same database, the factors significantly
associated with waiting list death were the need for
dialysis or any form of renal replacement therapy (P 
0.0001) and location in an ICU at the time of listing (Sue
McDiarmid, personal communication, June 2006). A
modified MELD or PELD score for acute liver failure
may more accurately prioritize acute liver failure pa-
tients on the waiting list. Such a modification could be
important for patients who do not qualify for status 1A
listing, and it might also allow better prioritization of
TABLE 5. Status 1A and 1B Criteria for Adults and Children*
Status 1A (adults and children) Must have diagnosis of fulminant liver failure and must be in ICU plus at
least one of the following:
On ventilator
Renal failure requiring dialysis of continuous veno-venous hemofiltration
or continuous veno-venous hemodialysis
INR 2.0
Status 1B (children only) Must be in ICU with chronic liver disease and must have PELD 25 and
at least one of the following:
On ventilator
Gastrointestinal bleeding requiring at least 30 mL/kg of packed red blood
cell transfusion in the previous 24 hours
Renal failure requiring dialysis of continuous veno-venous hemofiltration
or continuous veno-venous hemodialysis
Glasgow Coma Score  10
Abbreviations: ICU, intensive care unit; INR, international normalized ratio of prothrombin time; PELD, Pediatric End-Stage
Liver Disease.
*Additional definitions for status 1A listing for primary nonfunction and hepatic artery thrombosis are also provided. The
complete policy can be found at the Organ Procurement and Transplantation Network (http://www.optn.org/).
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patients within status 1, for whom waiting time is a
metric now used to rank organ offers.
In conclusion, these analyses make clear that the
original intent of the status 1 designation has been
subverted by the inclusion of substantial numbers of
candidates, particularly children, with widely varying
risks of death on the waiting list. As long as waiting time
governed organ allocation in this diverse group of pa-
tients, the concept of medical urgency was largely lost.
The new definitions of status 1A and 1B seek to pro-
mote access to donor organs to those patients with a
similarly high risk of death, and appropriately distin-
guishes those with acute liver failure from children with
severe chronic liver failure. Essential to the success of
this concept is the broader regional sharing of pediatric
deceased donor livers to this most urgent group of pa-
tients. Additional benefits anticipated but as yet un-
proven are a decrease in deaths on the waiting list, and
a potential improvement in posttransplant outcomes if
the patients with most urgent need receive more timely
liver transplants with better-quality organs.
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